Stryker sees $12.4B net sales in 2017; neurotechnology, spine sales reach $2.2B — 9 highlights

Written by Megan Wood | January 09, 2018 | Print  |

Stryker reported its preliminary results for the fourth quarter and full year of 2017.

Here are five highlights:

 

1. The company reported a 10 percent boost of net sales to $3.5 billion in the fourth quarter of 2017.

 

2. For the full year, net sales hit $12.4 billion, a 9.9 percent jump over 2016.

 

3. Domestically, net sales reached $2.5 billion in the fourth quarter and $9.1 billion for the full year of 2017. International sales reached $1 billion in the fourth quarter and $3.4 billion for the full year of 2017.

 

4. In the fourth quarter of 2017, the following segments grew:
• Neurotechnology and spine— 11.5 percent
• Orthopedics — 8.1 percent
• MedSurg —10.9 percent

 

5. For the full year of 2017, the segments increased:
• Neurotechnology and spine — 8.2 percent
• Orthopedics — 6.6 percent
• MedSurg — 13.6 percent

 

6. Neurotechnology and spine net sales increased to $600 million in the fourth quarter and $2.2 billion for the full year of 2017.

 

7. The orthopedics net sales reached $1.3 billion for the fourth quarter and $4.7 billion for the full year of 2017. Stryker installed 35 Mako robots around the world in the fourth quarter; U.S. knee sales increased 10.5 percent in the quarter.

 

8. MedSurg net sales rose to $1.6 billion for the fourth quarter and $5.6 billion for the full year of 2017.

 

9. Stryker anticipates 2017 adjusted net earnings per diluted share to land near the high end of the previously reported range of $6.45 to $6.50.

 

More articles on devices:
Providence Medical Technology names new executive; reports 2 new studies: 5 insights
Alphatec reports $25M+ in 2017 revenue — 5 points
SeaSpine to see 2017 revenue of $34M+ — 7 observations

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months